Sign up to save your podcasts
Or
Share A Feasbility Evaluating the Use of Home OCT for a Clinical Trial of Faricimab Treatment of nAMD
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A Feasbility Evaluating the Use of Home OCT for a Clinical Trial of Faricimab Treatment of nAMD
We discuss the feasibility of using home OCT vs. a treat and extend approach in a clinical trial of faricimab in neovascular AMD with Dr. Kevin Blinder of the Retina Institute in Saint Louis, Mo and Profesor of Ophthalmology at Washington University School of Medicine.
View all episodes
By Retina Synthesis
4.5
88 ratings
We discuss the feasibility of using home OCT vs. a treat and extend approach in a clinical trial of faricimab in neovascular AMD with Dr. Kevin Blinder of the Retina Institute in Saint Louis, Mo and Profesor of Ophthalmology at Washington University School of Medicine.
More shows like Retina Synthesis
View all
Ophthalmology off the Grid by Eyetube
43 Listeners
New Retina Radio by Eyetube
18 Listeners
Straight From The Cutter's Mouth: A Retina Podcast
97 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
The Journal.
6,068 Listeners
MedEdTalks - Ophthalmology
4 Listeners
Headlight in the fog: The Uveitis Podcast
21 Listeners
Pupil Pod
10 Listeners
Experts InSight
50 Listeners
RETINA Journal Podcasts
11 Listeners
Ophthalmology Journal
19 Listeners
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
0 Listeners
Talking Euretina
1 Listeners
Mayo Clinic Ophthalmology Podcast
18 Listeners
ASRS's History of Retina
0 Listeners